CStone Pharmaceuticals (HKSE:02616) Other Long-Term Liabilities : HK$0.0 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Other Long-Term Liabilities?

CStone Pharmaceuticals's other long-term liabilities for the quarter that ended in Jun. 2023 was HK$0.0 Mil.

CStone Pharmaceuticals's quarterly other long-term liabilities increased from Jun. 2022 (HK$1.2 Mil) to Dec. 2022 (HK$1.4 Mil) but then declined from Dec. 2022 (HK$1.4 Mil) to Jun. 2023 (HK$0.0 Mil).

CStone Pharmaceuticals's annual other long-term liabilities declined from Dec. 2021 (HK$1.5 Mil) to Dec. 2022 (HK$1.4 Mil) but then increased from Dec. 2022 (HK$1.4 Mil) to Dec. 2023 (HK$143.0 Mil).

CStone Pharmaceuticals Other Long-Term Liabilities Historical Data

The historical data trend for CStone Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Other Long-Term Liabilities Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

CStone Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

CStone Pharmaceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (HKSE:02616) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

CSPHF:USA PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (HKSE:02616) Headlines

No Headlines